WP
BTX.WS

WealthPLAN Partners’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

WealthPLAN Partners’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-272
Closed -$64 – 1113
2016
Q2 		$64 Buy
+272
New +$148 ﹤0.01% 2445
2015
Q4 		$42 Buy
+105
New +$107 ﹤0.01% 1672
2015
Q2 		$0 Hold
35
– – ﹤0.01% 531
2015
Q1 		$0 Buy
+35
New +$47 ﹤0.01% 545

Other funds holding BTX.WS

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

WealthPLAN Partners's BTX.WS Position: Q3 2016 in Review

WealthPLAN Partners sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2016, closing a stake of 272 shares — an estimated $64 sold.

WealthPLAN Partners first reported a position in BTX.WS in Q1 2015 and held it in 4 quarters. The position peaked at $64 in Q2 2016. 35 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2016.

  • WealthPLAN Partners reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2016 after selling out during the quarter.
  • WealthPLAN Partners sold 272 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2016, an estimated $64.
  • WealthPLAN Partners first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q1 2015 and held it in 4 quarters.
  • WealthPLAN Partners's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $64 in Q2 2016.
  • 35 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2016.

Based on WealthPLAN Partners's 13F filing for Q3 2016, filed 9 Dec 2016.